SCHEMBL6555537

SCHEMBL6555537

CCC(CC)(CN)NC(=O)c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
MAPK1 P28482 1/20 0.52
HDAC1 Q13547 2/20 0.51
HDAC6 Q9UBN7 1/20 0.51
THRB P10828 1/20 0.51
RAB9A P51151 4/20 0.50
NPC1 O15118 2/20 0.50
HDAC3 O15379 1/20 0.50
HDAC2 Q92769 1/20 0.50
ALDH1A1 P00352 4/20 0.49
GAA P10253 3/20 0.49
LMNA P02545 2/20 0.49
KDM4E B2RXH2 1/20 0.49
NPSR1 Q6W5P4 2/20 0.48
MAPT P10636 1/20 0.48
GFER P55789 1/20 0.48
HIF1A Q16665 1/20 0.48
APP P05067 1/20 0.47
HCAR3 P49019 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10898094 0.84 SMN1; SMN2 (0.51) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL10896464 0.82 HDAC1 (0.54) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL5939832 0.82 POLB (0.51) SMN1; SMN2HDAC1HDAC6RAB9ANPC1
SCHEMBL3536058 0.81 HDAC1 (0.56) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL31268672 0.77 HDAC1 (0.62) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL2732281 0.77 HDAC1 (0.62) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL11985607 0.76 HDAC1 (0.52) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL19379990 0.75 HDAC1 (0.55) SMN1; SMN2MAPK1HDAC1HDAC6THRB
SCHEMBL15638588 0.75 SMN1; SMN2 (0.53) SMN1; SMN2MAPK1HDAC1HDAC6THRB
Niacin SCHEMBL31228985 0.75 ALDH1A1 (0.78) SMN1; SMN2HDAC1HDAC6THRBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927030-B1 USE OF ARYL N-SUBSTITUTED CARBOXAMIDES TO KILL TUMORS OXIGENE INC (US) 2004-12-22 EP disclosed
EP-0927030-A4 USE OF ARYL N-SUBSTITUTED CARBOXAMIDES TO KILL TUMORS OXIGENE INC (US) 2000-01-26 EP disclosed
EP-0927030-A1 USE OF ARYL N-SUBSTITUTED CARBOXAMIDES TO KILL TUMORS OXIGENE, INC. (US) 1999-07-07 EP disclosed
WO-1997032576-A1 USE OF ARYL N-SUBSTITUTED CARBOXAMIDES TO KILL TUMORS OXIGENE, INC. (US) 1997-09-12 WO disclosed